Abbott Laboratories Share Price Swiss Exchange

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange 10:01:05 19/02/2024 pm IST 5-day change 1st Jan Change
93 CHF -.--% Intraday chart for Abbott Laboratories -.--% -.--%

Financials

Sales 2024 * 41.72B 37.03B 3,480B Sales 2025 * 44.73B 39.7B 3,731B Capitalization 180B 160B 15,011B
Net income 2024 * 5.98B 5.31B 499B Net income 2025 * 7.17B 6.36B 598B EV / Sales 2024 * 4.44 x
Net Debt 2024 * 5.47B 4.86B 456B Net Debt 2025 * 112M 99.48M 9.35B EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
29.9 x
P/E ratio 2025 *
25.8 x
Employees 1,14,000
Yield 2024 *
2.11%
Yield 2025 *
2.27%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 week
93.00
Extreme 93
93.00
1 month
93.00
Extreme 93
93.00
Current year
93.00
Extreme 93
93.00
1 year
89.00
Extreme 89
93.50
3 years
89.00
Extreme 89
128.00
5 years
70.00
Extreme 70
128.00
10 years
34.75
Extreme 34.75
128.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/15/01
Director of Finance/CFO 51 01/97/01
Chief Tech/Sci/R&D Officer - 01/90/01
Members of the board TitleAgeSince
Director/Board Member 69 16/17/16
Director/Board Member 63 29/17/29
Director/Board Member 65 09/11/09
More insiders
Date Price Change
17/24/17 93 -.--%
14/24/14 93 -.--%
13/24/13 93 -.--%
12/24/12 93 -.--%
11/24/11 93 -.--%

Delayed Quote Swiss Exchange, February 19, 2024 at 10:01 pm IST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.19%
Consensus